Montserrat Ferrer-Batallé

Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes

Esther Llop, Montserrat Ferrer-Batallé, Sílvia Barrabés et al. · Theranostics · 2016 · 136 citations · Full text

Glycobiology, Pathology, Glycoproteomics +17

Comparative Study of Blood-Based Biomarkers, α2,3-Sialic Acid PSA and PHI, for High-Risk Prostate Cancer Detection

Montserrat Ferrer-Batallé, Esther Llop, Manel Ramírez et al. · International Journal of Molecular Sciences · 2017 · 56 citations · Full text

Blood-based Biomarkers, Pathology, Biomarker (Medicine) +17

Characterisation of the main PSA glycoforms in aggressive prostate cancer

Anna Gratacós-Mulleras, Adrià Duran, Akram Asadi Shehni et al. · Scientific Reports · 2020 · 33 citations · Full text

Development of an Epidermal Growth Factor Derivative with EGFR Blocking Activity

Clara Panosa, Francesc Tebar, Montserrat Ferrer-Batallé et al. · PLoS ONE · 2013 · 21 citations · Full text

Epidermal Growth Factor, Erbb Receptors, Human Growth +17

Analysis of urinary PSA glycosylation is not indicative of high-risk prostate cancer

Sílvia Barrabés, Esther Llop, Montserrat Ferrer-Batallé et al. · Clinica Chimica Acta · 2017 · 14 citations

Glycoproteomics, Urology, High-risk Prostate Cancer +8